Corpus Intelligence IC Memo — KANSAS HEART HOSPITAL 2026-04-26 05:27 UTC
IC Memo — KANSAS HEART HOSPITAL
Investment Committee Memorandum | KS | 46 beds | Grade D | EBITDA uplift $3.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KANSAS HEART HOSPITAL

CCN 170186 | SEDGWICK, KS | 46 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

KANSAS HEART HOSPITAL is a 46-bed community hospital in SEDGWICK, KS with $41.1M in net patient revenue and a -0.7% operating margin. The hospital serves a payer mix of 52.1% Medicare, 0.0% Medicaid, and 47.9% commercial.

Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.7% to 6.7% (+736bps).

Net Revenue HCRIS$41.1M
Current EBITDA COMPUTED$-278K
Operating Margin COMPUTED-0.7%
Occupancy HCRIS37.7%
Revenue / Bed COMPUTED$893K
Net-to-Gross HCRIS33.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
80
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -0.7% places it above the state median. Among 80 size-comparable peers (23-92 beds), the median margin is -17.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (23-92), prioritizing same-state peers. 80 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KANSAS HEART HOSPITAL (Target)KS46$41.1M-0.7%
ST. LUKES SOUTHKS91$218.2M-13.1%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
CENTURA ST. CATHERINE - GARDENKS90$107.1M-8.1%
MERCY REGIONAL HEALTH CENTERKS84$95.8M0.8%
NEWTON MEDICAL CENTERKS76$93.2M-7.9%
VIA CHRISTI HOSPITAL PITTSBURGKS64$90.4M-16.9%
LABETTE COUNTY MEDICAL CENTERKS49$80.6M-14.3%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$863K+210bp18mo
Cost to Collect4.5%2.5%$822K+200bp12mo
Denial Rate Reduction12.0%6.5%$813K+198bp12mo
A/R Days Reduction5200.0%3800.0%$500K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$863K
Cost to Collect
$822K
Denial Rate Reduction
$813K
A/R Days Reduction
$500K
Clean Claim Rate
$26K
Total EBITDA Uplift$3.0M
Current EBITDA$-278K
+ RCM Uplift+$3.0M
Pro Forma EBITDA$2.7M
Current Margin-0.7%
Pro Forma Margin6.7%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-428K$28.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-428K$31.1M0.00x-100.0%
Bull Case9.0x11.0x$-385K$40.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-385K$44.6M0.00x-100.0%
Bear Case11.0x10.0x$-471K$13.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-471K$14.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 80 hospitals with 23-92 beds
  • Same-state prioritization (n=81)
  • Comp margins: P25=-28.5% / P50=-17.7% / P75=-7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.